BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16291991)

  • 1. Bone marrow micrometastases in breast cancer.
    Jeruss JS; Kuerer HM
    N Engl J Med; 2005 Nov; 353(20):2191; author reply 2191. PubMed ID: 16291991
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow micrometastases and adjuvant treatment of breast cancer.
    Yu JJ; Brennan M; Christos P; Osborne MP; Hoda S; Simmons RM
    Breast J; 2004; 10(3):181-5. PubMed ID: 15125741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.
    Saha S; Ali S; Ghanem M; Soni M; Wiese D; Arora M; Singh T; Iddings D
    Ann Surg Oncol; 2009 Feb; 16(2):276-80. PubMed ID: 19050967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of bone marrow micrometastases of breast tumors].
    Dubecz S; Csuka O; Török K; Vasas N; Péley G; Doleschal Z; Sulyok Z; Láng I; Köves I
    Magy Seb; 2003 Aug; 56(3-4):108-12. PubMed ID: 14619093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.
    Becker S; Becker-Pergola G; Wallwiener D; Solomayer EF; Fehm T
    Breast Cancer Res Treat; 2006 May; 97(1):91-6. PubMed ID: 16319975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.
    Müller V; Stahmann N; Riethdorf S; Rau T; Zabel T; Goetz A; Jänicke F; Pantel K
    Clin Cancer Res; 2005 May; 11(10):3678-85. PubMed ID: 15897564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Axillary lymph node and bone marrow micrometastases of breast cancer].
    Nahon S; Brewer Y; Kirscher S; Chauvet B; Berger C; Serin D
    Bull Cancer; 2001 Nov; 88(11):1095-104. PubMed ID: 11741804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
    Braun S; Schlimok G; Heumos I; Schaller G; Riethdorf L; Riethmüller G; Pantel K
    Cancer Res; 2001 Mar; 61(5):1890-5. PubMed ID: 11280743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
    Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pooled analysis of bone marrow micrometastasis in breast cancer.
    Braun S; Vogl FD; Naume B; Janni W; Osborne MP; Coombes RC; Schlimok G; Diel IJ; Gerber B; Gebauer G; Pierga JY; Marth C; Oruzio D; Wiedswang G; Solomayer EF; Kundt G; Strobl B; Fehm T; Wong GY; Bliss J; Vincent-Salomon A; Pantel K
    N Engl J Med; 2005 Aug; 353(8):793-802. PubMed ID: 16120859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
    Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
    Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.
    Langer I; Guller U; Koechli OR; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M;
    Ann Surg Oncol; 2007 Jun; 14(6):1896-903. PubMed ID: 17356955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow micrometastases in early breast cancer-30-year outcome.
    Mansi J; Morden J; Bliss JM; Neville M; Coombes RC
    Br J Cancer; 2016 Feb; 114(3):243-7. PubMed ID: 26766739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do bone marrow micrometastases correlate with sentinel lymph node metastases in breast cancer patients?
    Trocciola SM; Hoda S; Osborne MP; Christos PJ; Levin H; Martins D; Carson J; Daly J; Simmons RM
    J Am Coll Surg; 2005 May; 200(5):720-5; discussion 725-6. PubMed ID: 15848362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial quantitative PCR analysis of bone marrow samples from breast cancer patients to monitor systemic micrometastases.
    Shammas FV; Deak E; Nysted A; van Eekelen JA; Osland A; Heikkilä R
    Anticancer Res; 2001; 21(3C):2099-106. PubMed ID: 11501832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of the hemoglobin concentration on the hematogenous tumor cell dissemination at the time of the initial diagnosis of breast cancer].
    Janni W; Strobl B; Rack B; Rjosk D; Schindlbeck C; Hantschmann P; Kentenich C; Sigg W; Zerzer M; Sommer H
    Dtsch Med Wochenschr; 2002 Jan; 127(3):71-7. PubMed ID: 11797143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer.
    Hohaus S; Funk L; Martin S; Schlenk RF; Abdallah A; Hahn U; Egerer G; Goldschmidt H; Schneeweiss A; Fersis N; Kaul S; Wallwiener D; Bastert G; Haas R
    Br J Cancer; 1999 Mar; 79(9-10):1500-7. PubMed ID: 10188897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow micrometastases and markers of angiogenesis in esophageal cancer.
    Spence GM; Graham AN; Mulholland K; Maxwell P; McCluggage WG; Sloan JM; McGuigan JA
    Ann Thorac Surg; 2004 Dec; 78(6):1944-9; discussion 1950. PubMed ID: 15561005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and clinical significance of disseminated tumor cells in bone marrow].
    Braun S; Pantel K
    Dtsch Med Wochenschr; 2000 Oct; 125(41):1237-9. PubMed ID: 11076263
    [No Abstract]   [Full Text] [Related]  

  • 20. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.